An amphotericin B-based drug for treating experimental Leishmania major infection

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 104, Issue 11, 2010, Pages 749-750

  Corware, Karina D ^a   Rogers, Matthew ^b   Teo, Ian ^a   Müller, Ingrid ^b   Shaunak, Sunil ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Amphotericin B; Cutaneous leishmaniasis; Immunomodulatory therapy; Leishmania major; Pharmacological therapy; Poly(methacrylic acid)

Indexed keywords

AMPHOTERICIN B DERIVATIVE; AMPHOTERICIN B POLY(METHACRYLIC ACID); GAMMA INTERFERON; INTERLEUKIN 10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SYNTHESIS; EXPERIMENTAL INFECTION; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; MOUSE; NONHUMAN; SKIN LEISHMANIASIS;

AMPHOTERICIN B; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIPROTOZOAL AGENTS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C;

LEISHMANIA MAJOR; MUS;

EID: 77957958897     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2010.08.010     Document Type: Article

References (5)

1. Sundar S., Mehta H., Suresh A.V., Singh S.P., Rai M., Murray H.W. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin Infect Dis 2004, 38:377-383.
2. Yardley V., Croft S.L. A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis. Int J Antimicrob Agents 2000, 13:243-248.
3. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002, 2:845-858.
4. Vouldoukis I., Bécherel P.A., Riveros-Moreno V., Arock M., da Silva O., Debré P., et al. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 1997, 27:860-865.
5. Bogdan C., Moll H., Solbach W., Rollinghoff M. Tumour necrosis factor-alpha in combination with interferon-gamma but not with interleukin-4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol 1990, 20:1131-1135.